Apart from the Nrf2 signal pathway, silymarin can also downregulate the NF-κB pathway to reduce the production of proinflammatory cytokines and reduce the inflammatory response that stimulates atherosclerosis [14]. The gene discussed is NFKB1; the disease is atherosclerosis.